Literature DB >> 3223903

1H- and 13C-n.m.r. studies of the antitumour antibiotic luzopeptin. Resonance assignments, conformation and flexibility in solution.

M S Searle1, J G Hall, P G Wakelin.   

Abstract

The depsipeptide DNA-intercalating antibiotic luzopeptin was studied in solution by n.m.r. methods. Two-dimensional 1H double-quantum-filtered correlation spectroscopy (DQF-COSY) and nuclear-Overhauser-effect spectroscopy (NOESY) confirm the primary structure and twofold symmetry of luzopeptin and provide details of its three-dimensional conformation in solution. Trans-annular hydrogen bonds between the glycine NH groups and carbonyl oxygen atoms have been identified in the crystalline state [Arnold & Clardy (1981) J. Am. Chem. Soc. 103, 1243-1244], and are important in maintaining an antiparallel beta-sheet conformation. The n.m.r. data indicate that the glycine NH protons are appreciably shielded from the solvent molecules, which suggests that these hydrogen bonds are maintained in solution. The orientation of the quinoline chromophores is defined by two-dimensional NOE cross-peaks that position the N-methyl group of the L-beta-hydroxyvaline residue close in space to both the quinoline H-8 and serine NH proton. This pattern of NOEs is in accord both with the chromophore configuration found in the crystal and one where the quinoline rings are aligned in a parallel manner at right-angles to the depsipeptide ring. The n.m.r. data are consistent with a hydrogen bond between the quinoline hydroxy groups and the quinoline carbonyl oxygen atoms. The pyridazine acetylmethyl groups give NOEs to the C(alpha)H groups of the beta-hydroxy-N-methylvaline residues, showing that the acetyl groups, for at least some of the time, stretch over the depsipeptide ring, occluding one face of the molecule. Both of the latter features are also found in the crystal structure. Resonances in the 13C-n.m.r. spectrum of luzopeptin have been assigned by transferring 1H assignments to their covalently bonded carbon atoms via a heteronuclear shift-correlation experiment (HETCOR). The measurement of spin-lattice relaxation times and 1H-13C NOEs at specific sites in the molecule has led us to conclude that segmental motions within the depsipeptide ring are restricted and that the 13C relaxation data for luzopeptin's protonated carbon atoms are adequately described by isotropic tumbling in solution. Furthermore, relaxation data for the carbon atoms of the quinoline chromophores show that these rings exhibit similar motion to the depsipeptide ring and are not rotating rapidly with respect to it. Taken together all the data imply that luzopeptin is fairly rigid in solution, on the time scale of molecular tumbling, and has, or can readily attain, a staple-like structure suitable for bisintercalation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3223903      PMCID: PMC1135398          DOI: 10.1042/bj2560271

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Carbon-13 magnetic resonance study of structural and dynamical features in carbamylated insulins.

Authors:  J J Led; D M Grant; W J Horton; F Sundby; K Vihelmsen
Journal:  J Am Chem Soc       Date:  1975-10-15       Impact factor: 15.419

2.  Conformational flexibility of angiotensin II. A carbon-13 spin-lattice relaxation study.

Authors:  R Deslauriers; A C Paiva; K Schaumburg; I C Smith
Journal:  Biochemistry       Date:  1975-03-11       Impact factor: 3.162

3.  Peptide models of electrostatic interactions in proteins: NMR studies on two beta-turn tetrapeptides containing Asp-His and Asp-Lys salt bridges.

Authors:  D Sahal; P Balaram
Journal:  Biochemistry       Date:  1986-10-07       Impact factor: 3.162

4.  Conformational mobility of the pyrrolidine ring of proline in peptides and peptide hormones as manifest in carbon 13 spin-lattice relaxation times.

Authors:  R Deslauriers; I C Smith; R Walter
Journal:  J Biol Chem       Date:  1974-11-10       Impact factor: 5.157

5.  Echinomycin: a bifunctional intercalating antibiotic.

Authors:  M J Waring; L P Wakelin
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

6.  Conformation and segmental motion of native and denatured ribonuclease A in solution. Application of natural-abundance carbon-13 partially relaxed Fourier transform nuclear magnetic resonance.

Authors:  A Allerhand; D Doddrell; V Glushko; D W Cochran; E Wenkert; P J Lawson; F R Gurd
Journal:  J Am Chem Soc       Date:  1971-01-27       Impact factor: 15.419

7.  BBM-928, a new antitumor antibiotic complex. II. Taxonomic studies on the producing organism.

Authors:  K Tomita; Y Hoshino; T Sasahira; H Kawaguchi
Journal:  J Antibiot (Tokyo)       Date:  1980-10       Impact factor: 2.649

8.  Conformational flexibility of luteinizing hormone-releasing hormone in aqueous solution. A carbon-13 spin-lattice relaxation time study.

Authors:  R Deslauriers; G C Levy; W H McGregor; K Sarantakis; I C Smith
Journal:  Biochemistry       Date:  1975-09-23       Impact factor: 3.162

9.  BBM-928, a new antitumor antibiotic complex. I. Production, isolation, characterization and antitumor activity.

Authors:  H Ohkuma; F Sakai; Y Nishiyama; M Ohbayashi; H Imanishi; M Konishi; T Miyaki; H Koshiyama; H Kawaguchi
Journal:  J Antibiot (Tokyo)       Date:  1980-10       Impact factor: 2.649

10.  The binding of echinomycin to deoxyribonucleic acid.

Authors:  S P Wakelin; M J Waring
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

View more
  2 in total

1.  Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance().

Authors:  Arthur C Rand; Siegfried S F Leung; Heather Eng; Charles J Rotter; Raman Sharma; Amit S Kalgutkar; Yizhong Zhang; Manthena V Varma; Kathleen A Farley; Bhagyashree Khunte; Chris Limberakis; David A Price; Spiros Liras; Alan M Mathiowetz; Matthew P Jacobson; R Scott Lokey
Journal:  Medchemcomm       Date:  2012-10       Impact factor: 3.597

2.  Interaction of the antitumour antibiotic luzopeptin with the hexanucleotide duplex d(5'-GCATGC)2. One-dimensional and two-dimensional n.m.r. studies.

Authors:  M S Searle; J G Hall; W A Denny; L P Wakelin
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.